Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 226

1.

Liver imaging reporting and data system category M: A systematic review and meta-analysis.

Kim DH, Choi SH, Park SH, Kim KW, Byun JH, Kim SY, Lee SS, Shin YM, Won HJ, Kim PN.

Liver Int. 2020 Mar 4. doi: 10.1111/liv.14420. [Epub ahead of print]

PMID:
32129541
2.

Percutaneous Radiofrequency Ablation for Metachronous Hepatic Metastases after Curative Resection of Pancreatic Adenocarcinoma.

Lee SJ, Kim JH, Kim SY, Won HJ, Shin YM, Kim PN.

Korean J Radiol. 2020 Mar;21(3):316-324. doi: 10.3348/kjr.2019.0647.

3.

Ancillary features in the Liver Imaging Reporting and Data System: how to improve diagnosis of hepatocellular carcinoma ≤ 3 cm on magnetic resonance imaging.

Kang JH, Choi SH, Byun JH, Kim DH, Lee SJ, Kim SY, Won HJ, Shin YM, Kim PN.

Eur Radiol. 2020 Feb 4. doi: 10.1007/s00330-019-06645-3. [Epub ahead of print]

PMID:
32020399
4.

Meta-analysis of the accuracy of Liver Imaging Reporting and Data System category 4 or 5 for diagnosing hepatocellular carcinoma.

Kim DH, Choi SH, Park SH, Kim KW, Byun JH, Kim SY, Lee SS, Shin YM, Won HJ, Kim PN.

Gut. 2019 Sep;68(9):1719-1721. doi: 10.1136/gutjnl-2019-318555. Epub 2019 Jul 12. No abstract available.

PMID:
31300516
5.

Radiomics Analysis of Gadoxetic Acid-enhanced MRI for Staging Liver Fibrosis.

Park HJ, Lee SS, Park B, Yun J, Sung YS, Shim WH, Shin YM, Kim SY, Lee SJ, Lee MG.

Radiology. 2019 Jul;292(1):269. doi: 10.1148/radiol.2019194012. No abstract available.

PMID:
31219760
6.

Arterial subtraction images of gadoxetate-enhanced MRI improve diagnosis of early-stage hepatocellular carcinoma.

Kim DH, Choi SH, Byun JH, Kang JH, Lim YS, Lee SJ, Kim SY, Won HJ, Shin YM, Kim PN.

J Hepatol. 2019 Sep;71(3):534-542. doi: 10.1016/j.jhep.2019.05.005. Epub 2019 May 18.

PMID:
31108157
7.

Radiomics Analysis of Gadoxetic Acid-enhanced MRI for Staging Liver Fibrosis.

Park HJ, Lee SS, Park B, Yun J, Sung YS, Shim WH, Shin YM, Kim SY, Lee SJ, Lee MG.

Radiology. 2019 Feb;290(2):380-387. doi: 10.1148/radiol.2018181197. Epub 2018 Dec 4. Erratum in: Radiology. 2019 Jul;292(1):269.

PMID:
30615554
8.

LI-RADS Classification and Prognosis of Primary Liver Cancers at Gadoxetic Acid-enhanced MRI.

Choi SH, Lee SS, Park SH, Kim KM, Yu E, Park Y, Shin YM, Lee MG.

Radiology. 2019 Feb;290(2):388-397. doi: 10.1148/radiol.2018181290. Epub 2018 Nov 13.

PMID:
30422088
9.

The effectiveness of transarterial chemoembolization in recurrent hepatocellular-cholangiocarcinoma after resection.

Na SK, Choi GH, Lee HC, Shin YM, An J, Lee D, Shim JH, Kim KM, Lim YS, Chung YH, Lee YS.

PLoS One. 2018 Jun 7;13(6):e0198138. doi: 10.1371/journal.pone.0198138. eCollection 2018.

10.

Liver Imaging Reporting and Data System: Patient Outcomes for Category 4 and 5 Nodules.

Choi SH, Byun JH, Lim YS, Lee SJ, Kim SY, Won HJ, Shin YM, Kim PN.

Radiology. 2018 May;287(2):515-524. doi: 10.1148/radiol.2018170748. Epub 2018 Feb 19.

PMID:
29457964
11.

Clinical Outcomes of Radiofrequency Ablation for Early Hypovascular HCC: A Multicenter Retrospective Study.

Lee DH, Lee JM, Kang TW, Rhim H, Kim SY, Shin YM, Seo JW, Choi MH, Lee KB.

Radiology. 2018 Jan;286(1):338-349. doi: 10.1148/radiol.2017162452. Epub 2017 Oct 5.

PMID:
28981400
12.

Utility and Safety of Repeated Ultrasound-Guided Core Needle Biopsy of Focal Liver Masses.

Kim JS, Won HJ, Lee SJ, Kim SY, Shin YM, Kim PN.

J Ultrasound Med. 2018 Feb;37(2):447-452. doi: 10.1002/jum.14358. Epub 2017 Aug 29.

PMID:
28850692
13.

Efficacy and Safety of Radiofrequency Ablation for Focal Hepatic Lesions Adjacent to Gallbladder: Reconfiguration of the Ablation Zone through Probe Relocation and Ablation Time Reduction.

Choi IY, Kim PN, Lee SG, Won HJ, Shin YM.

J Vasc Interv Radiol. 2017 Oct;28(10):1395-1399. doi: 10.1016/j.jvir.2017.06.004. Epub 2017 Jul 23.

PMID:
28747272
14.

Efficacy and safety of ultrasound-guided implantation of fiducial markers in the liver for stereotactic body radiation therapy.

Park SH, Won HJ, Kim SY, Shin YM, Kim PN, Yoon SM, Park JH, Kim JH.

PLoS One. 2017 Jun 21;12(6):e0179676. doi: 10.1371/journal.pone.0179676. eCollection 2017.

15.

Value of contrast-enhanced sonography of small hepatocellular carcinoma with sonazoid prior to radiofrequency ablation.

Lee SJ, Won HJ, Kim KW, Shin YM, Kim PN.

J Clin Ultrasound. 2017 Sep;45(7):383-390. doi: 10.1002/jcu.22469. Epub 2017 Mar 8.

PMID:
28271531
16.

Embolization for Bleeding after Hepatic Radiofrequency Ablation.

Kim JW, Shin JH, Kim PN, Shin YM, Won HJ, Ko GY, Yoon HK.

J Vasc Interv Radiol. 2017 Mar;28(3):356-365.e2. doi: 10.1016/j.jvir.2016.09.031. Epub 2016 Dec 21.

PMID:
28012690
17.

Combined hepatocellular-cholangiocarcinoma: Gadoxetic acid-enhanced MRI findings correlated with pathologic features and prognosis.

Park SH, Lee SS, Yu E, Kang HJ, Park Y, Kim SY, Lee SJ, Shin YM, Lee MG.

J Magn Reson Imaging. 2017 Jul;46(1):267-280. doi: 10.1002/jmri.25568. Epub 2016 Nov 22.

PMID:
27875000
18.

Intravoxel incoherent motion diffusion-weighted imaging for characterizing focal hepatic lesions: Correlation with lesion enhancement.

Choi IY, Lee SS, Sung YS, Cheong H, Lee H, Byun JH, Kim SY, Lee SJ, Shin YM, Lee MG.

J Magn Reson Imaging. 2017 Jun;45(6):1589-1598. doi: 10.1002/jmri.25492. Epub 2016 Sep 24.

PMID:
27664970
19.

Liver Imaging Reporting and Data System v2014 With Gadoxetate Disodium-Enhanced Magnetic Resonance Imaging: Validation of LI-RADS Category 4 and 5 Criteria.

Choi SH, Byun JH, Kim SY, Lee SJ, Won HJ, Shin YM, Kim PN.

Invest Radiol. 2016 Aug;51(8):483-90. doi: 10.1097/RLI.0000000000000258.

PMID:
26885632
20.

Diagnostic criteria for hepatocellular carcinoma ⩽3 cm with hepatocyte-specific contrast-enhanced magnetic resonance imaging.

Choi SH, Byun JH, Lim YS, Yu E, Lee SJ, Kim SY, Won HJ, Shin YM, Kim PN.

J Hepatol. 2016 May;64(5):1099-1107. doi: 10.1016/j.jhep.2016.01.018. Epub 2016 Jan 25.

PMID:
26820629

Supplemental Content

Loading ...
Support Center